Grünenthal
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Grünenthal sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Grünenthal: 16 sponsored US clinical trials, none currently recruiting.
Grünenthal sponsors 16 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 11 completed. 8 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Complex Regional Pain Syndrome, with 1 trials.
Top-decile sponsor footprint
Grünenthal ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
11 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (68.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
16 total, page 1 of 1
A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants
NCT07317063
Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee
NCT05449132
Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee
NCT05377489
Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)
NCT03560986
Efficacy and Safety of Intravenous Neridronic Acid in CRPS
NCT03530345
Safety of Intravenous Neridronic Acid in CRPS
NCT02972359
Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
NCT02402530
A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain
NCT02081391
Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old
NCT02221674
Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain
NCT01729728
Intravenous Tapentadol in Post-Bunionectomy Pain
NCT01435577
Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain
NCT01043263
A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
NCT01056315
A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy
NCT00609466
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
NCT00505414
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
NCT03783910
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 8 |
Therapeutic Areas
How the Grünenthal archive is shaped
16 indexed studies, none listed as recruiting (0% open); 11 completed (69%).
Phase mix: 8 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Complex Regional Pain Syndrome (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Grünenthal: archived-pipeline peers nationwide
Peers matched on 16 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Grünenthal sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 archived trials
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Grünenthal page
16 registered trials is a research-attention snapshot, not an endorsement of Grünenthal or any single study.
- None of Grünenthal's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Complex Regional Pain Syndrome is the condition Grünenthal studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Complex Regional Pain Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Grünenthal pipeline card: 16 registered trials from official public datasets.Report a data error.